"10.1371_journal.pone.0149996","plos one","2016-03-02T00:00:00Z","Gregory J Crowther; Heidi K Hillesland; Katelyn R Keyloun; Molly C Reid; Maria Jose Lafuente-Monasterio; Sonja Ghidelli-Disse; Stephen E Leonard; Panqing He; Jackson C Jones; Mallory M Krahn; Jack S Mo; Kartheek S Dasari; Anna M W Fox; Markus Boesche; Majida El Bakkouri; Kasey L Rivas; Didier Leroy; Raymond Hui; Gerard Drewes; Dustin J Maly; Wesley C Van Voorhis; Kayode K Ojo","Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, United States of America; Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Madrid, Spain; Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline R&D, Heidelberg, Germany; Department of Chemistry, University of Washington, Seattle, Washington, United States of America; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada; Drug Discovery, Medicines for Malaria Venture, Geneva, Switzerland","Conceived and designed the experiments: GJC HKH MJLM SGD DL RH GD DJM WCVV KKO. Performed the experiments: GJC HKH KRK MCR MJLM SGD SEL PH JCJ MMK JSM KSD AMWF MB MEB KLR KKO. Analyzed the data: GJC HKH KRK MCR MJLM SGD SEL JCJ MMK JSM KSD AMWF MB MEB DJM WCVV KKO. Contributed reagents/materials/analysis tools: MJLM SGD SEL MB MEB RH DJM. Wrote the paper: GJC HKH MJLM SGD DL DJM WCVV KKO.","Several authors are employees of Cellzome GmbH or GlaxoSmithKline (GSK), which partially funded this work (in the form of employee salaries) and hold patent WO 2006/134056 on the kinobeads technology used in this study. Cellzome/GSK does not offer any commercial services related to this technology. DL is an employee of the Medicines for Malaria Venture (MMV), which partially funded this study. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2016","03","Gregory J Crowther","GJC",22,TRUE,10,17,17,8,TRUE,TRUE,FALSE,0,NA,FALSE
